↓ Skip to main content

Cochrane Database of Systematic Reviews

Tricyclic drugs for depression in children and adolescents

Overview of attention for article published in Cochrane database of systematic reviews, June 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
24 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
80 Dimensions

Readers on

mendeley
252 Mendeley
Title
Tricyclic drugs for depression in children and adolescents
Published in
Cochrane database of systematic reviews, June 2013
DOI 10.1002/14651858.cd002317.pub2
Pubmed ID
Authors

Philip Hazell, Mohsen Mirzaie

Abstract

There is a need to identify effective and safe treatments for depression in children and adolescents. While tricyclic drugs are effective in treating depression in adults, individual studies involving children and adolescents have been equivocal. Prescribing of tricyclic drugs for depression in children and adolescents is now uncommon, but an accurate estimate of their efficacy is helpful as a comparator for other drug treatments for depression in this age group. This is an update of a Cochrane review first published in 2000 and updated in 2002, 2006 and 2010.

Twitter Demographics

The data shown below were collected from the profiles of 24 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 252 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 <1%
United Kingdom 1 <1%
Spain 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 247 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 41 16%
Student > Master 37 15%
Researcher 26 10%
Student > Ph. D. Student 26 10%
Student > Doctoral Student 23 9%
Other 52 21%
Unknown 47 19%
Readers by discipline Count As %
Medicine and Dentistry 83 33%
Psychology 46 18%
Social Sciences 11 4%
Nursing and Health Professions 10 4%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Other 30 12%
Unknown 63 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2021.
All research outputs
#1,531,738
of 17,730,520 outputs
Outputs from Cochrane database of systematic reviews
#3,767
of 11,742 outputs
Outputs of similar age
#15,004
of 164,955 outputs
Outputs of similar age from Cochrane database of systematic reviews
#34
of 141 outputs
Altmetric has tracked 17,730,520 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,742 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.3. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,955 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.